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Cancer cervix is the most common genital cancer in developing countries 
and second most common genital cancer in developed countries. 
              Carcinoma cervix has long pre-invasive stage of over 10-15 years. 
Availability of effective screening programmes and effective treatment along with 
long pre-invasive stage, make road for reducing morbidity and mortality due to 
cervical cancer by early detection of pre-invasive lesions. Cervical cancer 
screening programmes to detect and treat cervical neoplasia have dramatic impact 
on incidence of invasive cancer. 
 
Incidence: 
                             Worldwide, cervical cancer is the third most common 
malignancy and second most common cancer after breast cancer in women. 
Highest incidence of disease is seen in Caribbean and African countries.  
                  Incidence in Africa  : 55/100,000 women 
                              New Delhi    : 20.5/100,000 women                                                     
                               Chennai      : 32.3 /100,000women 
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An estimated 4,70,000 new cases of cervical cancer are diagnosed each year 
world wide and 80% of them occur in developing countries. A quarter of global 
burden is experienced in India, where about 1, 26,000 new cases and 71,000 
deaths attributable to cervical cancer are estimated to occur each year. Cervical 
cancer constitute 15-55% of all female cancer and value of age standardized 
incidence ranges from 17.2 to 55 per 1 lakh women in different region in India 
with 5 year survival rate of  less than 40% as most are detected at advanced 
stage1. 
 
                                  Routine screening for cervical cancer with pap smear for all 
women who are or have been sexually active was done previously. In India, lack 
of experts in cytopathological studies and long period to get cytopathology report 
makes distinct need for alternate strategy.  Now visual inspection of cervix with 
acetic acid and lugol’s iodine is being recommended especially in low resource 
settings as a screening modality for cervical lesions. 
The primary goal of cervical screening is to prevent cervical cancer which is 
achieved by early detection; eradication and follow-up of pre-invasive cervical 
lesions. The ability to detect preinvasive cervical lesions coupled with easy 




Anatomy of cervix: 
 
   Cervix is the lower fibro muscular portion of uterus ,measures 3-4 cm in length 
and 2.5 cm in diameter. However, it varies in size and shape depending on age, 
parity and menstrual status of the women.  
                    Ectocervix is the most readily visible portion and the endocervix is 
largely invisible and lies proximal to the external os. 
Epithelium of cervix: 
         Endocervix is lined by tall columnar epithelium in single layer with basal 
solid nucleus2. On visual inspection ,it appears red in color as the underlying 
vasculature is readily visible through single layer of glandular epithelium. This 
epithelium is thrown into multiple longitudinal folds protruding into the lumen of 
the canal, giving rise to papillary projections. It invaginates into the substance of 
cervical stroma, resulting in formation of endocervical crypts, giving columnar 
epithelium a grainy appearance. Beneath this layer are cubical or reserve cells 
from which new surface cells are believed to develop and undergo squamous 
metaplasia. 
              Ectocervix lined by stratified squamous epithelium which is composed of 
4 layers. 
                 1. Superficial cell layer 
                 2. Intermediate cell layer 
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                 3. Parabasal layer 
                 4. Basal layer 
The important zones in colposcopy are: 
Squamo-columnar junction: 
                    Junction between stratified squamous epithelium and columnar 
epithelium 
 Transformation zone: 









NATURAL HISTORY OF DISEASE3: 
 
Understanding the natural history of various degrees of CIN is the cornerstone 
for the appropriate clinical management. 
In addition to the degree of dysplasia,it is likely that the course of a specific 
lesion is also influenced by number of other factors such as patient’s 








Natural History of HPV & Cervical Cancer
Persistence
















































Old Pap System 
 

















Epidemiological  model for cervical carcinogenesis 
 
Level of    Mild  Moderate  Severe  CIS 
Normal 
Dysplasia  
Normal        CIN I  CIN II                    CIN III              CIS 
               LSIL    HSIL 
Frequency 
Of spont.  40%     20%      1%    0 
regression   
Factors affecting natural history  
Malnutrition 
                       Vit A,C, β carotene 













Pathogenesis of CIN and invasive cancer: 
 
                                                 Sexual activity 
                                                        
                                                  Hpv exposure 
    
                                                  Cervical TZ 
 
 
         
                  Squamous  Epithelium                     columnar epithelium 
                                                                            
 
         Squamous intraepithelial  lesion              Glandular intra epithelial lesion 
                                                        
  
       Low grade                 High grade                    Adenocarcinoma  insitu 
                                                    
      Low risk                      High risk                        High risk  HPV-16,18 
HPV 6,11,42,44            HPV 16,18,33,35 
 
    Risk factors like smoking,high parity,altered immune status 
  








Approximate value of spontaneous regression or persistence and progression 
of CIN5. 
 
COURSE OF     
CIN 
CIN I CIN II CIN  III 
Regression to 
normal 
60% 40%- 50% 33% 
Persistence 
 
30% 40% 55% 
Progression to 
cancer 
1% 5% >12% 
      (Ref): OSTOR AG, Int j Gynaecol.pathology 1993. 















                     
Visual screening approaches: 
              Visual screening is a process of identifying cervical lesions with or 
without aided eye. Recently several researches has been undertaken to explain the 
accuracy and acceptability of visual inspection methods as a means of detecting 
pre-cancerous cervical lesions. Early methods included downstaging i.e., direct 
inspection of cervix by unaided eye. The outcome was not encouraging. So a 
promising approach VIA i.e., inspection of cervix after applying acetic acid 
which stains the abnormal areas white and VILI i.e., inspection of cervix after 
















Terminology used for visual screening methods7: 
Term used for method               magnification       enhancement 
1. Schiller’s test  
    Lugol’s iodine test                        no                       iodine 
    Visual inspection with 
     Lugol’s iodine 
2. Down staging                                  no                           no 
3. Direct visual inspection                  no                         3-5% acetic acid 
   Acetic acid washes 
   Acetic acid visualization   
   Acetic acid screening test 
 Visual inspection with acetic acid                                                                                         
  Acetic acid test 
4. Aided visual inspection               2.5-4 ×               3-5% acetic acid 
     Gynoscopy 
     Avioscopy 
     DVI with magnification 
     Visual inspection with acetic 
      Acid & magnification 
5. Speculoscopy                               4-6×                    3-5% acetic acid 








Visual inspection with acetic acid: 
Advantages: 
              Promising tool in low resource settings 
              Simple low tech approach 
              Minimally reliant on infrastructure for adequate performance   
              Cost for launching and sustaining is less than other methods 
              Sensitivity of VIA in detecting high grade lesions is near equal to         
     cytology though specificity is somewhat lower. 
 
 Pathophysiological basis of VIA: 
    On application of acetic acid, 
          Normal squamous epithelium appears pink and columnar epithelium 
appears as bright red due to reflection of light stroma that is highly vascular.    
Whitening effect of acetic acid depends upon the amount of cellular proteins 
present in the epithelium. Areas with increased nuclear activity and DNA content 
exhibit the most dramatic white color change. 
   Acetowhitening due to inflammation and healing is usually distributed widely 
and restricted to transformation zone and may quickly disappear .Acetowhitening 
of CIN takes up promptly and reverses very slowly. 
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Pathophysiological basis of VILI: 
 Normal glycogen containing squamous epithelium stains mahogany brown or 
black after application of iodine. 
Columnar epithelium does not take up iodine and remains unstained. 
Areas of CIN and invasive cancer do not take up iodine and appear as thick 
mustard yellow or saffron colored areas 
 
Colposcopy: 
                 In 1925, in Germany Hans Hinselmann introduced colposcopy. 
                 Plays singular role in early diagnosis of cancer cervix 
Colposcope is typically defined as a stereoscopic binocular field microscope with 
a long focal length and powerful light source. 
Modern colposcope permits magnification between 2X and 40X although most 
routine colposcopic work can be accomplished at 10X to 15X magnification. 
Indications for colposcopy: 
           Suspicious looking cervix 
           Invasive carcinoma on cytology 
           CIN 2 or CIN 3 on cytology 
           Persisting low grade abnormalities 
           CIN 1 on cytology 









           HPV infection 
           Aceto positivity on VIA  
           Positive lesion on VILI 
Advantages of colposcopy: 
           Both diagnostic and therapeutic procedures can be done. 
- to locate the lesions 
- selection of biopsy site  
- in selection of treatment of early invasive cancer and CIN 
-reduction in unnecessary biopsy 
-in the management of abnormal smear in pregnancy. 
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REVIEW OF LITERATURE: 
Pap smear has been recognized widely as the most effective cancer 
screening test in history of medicine. Pap smear introduced by George 
papanicoloau into clinical practice circa 1940. It was widely believed that use of 
this test has been responsible for drastic reduction in the incidence and mortality 
of cervical cancer in United States, Canada and much of Western Europe in the 
past 50 years. 
         The first documented incident of deficiencies in gynecologic cytology 
laboratories was reported by United States air force. Allegations that claimed 
inaccuracies on Pap smear diagnosis performed by contract laboratory between 
1972 -1977.8 
Limitations of conventional pap smear:9 
       1. Failure to capture the entire specimen obtained from the patient. 
       2. Inadequate fixation of the sample. 
       3. Random distribution of abnormal cells in the sample. 
       4. Obscuring elements such as blood, inflammation or thick areas of 
overlapping epithelial cells. 
        5. Technical variability in the quality of the smear 
These obstacles made a way to successful development of computer-assisted 
screening devices and liquid based cytology. 
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Liquid-based, thin layer cytology: 
            Liquid-based, thin layer cytology was developed to overcome the 
technical limitations of the conventional Pap smear. Limitations like failure to 
capture the entire specimen obtained from the patient and inadequate fixation are 
overcome by collection of cells directly into liquid fixative. 
            Limitation of random distribution of cells overcome by mechanical 
mixing of the cells creates a homogenous sample in which abnormal cells if 
present are evenly distributed throughout the sample assuring the sample 
homogenicity.10   
            Obscuring elements and technical variability in smear preparation 
addressed in different fashion by the procedures currently available.i.e Thin- prep, 
autocyte pap. Both these techniques result in consistent thin layer preparation of 
epithelial cells that are depleted of extraneous elements. 
 
Computer assisted screening devices: 
Computer assisted devices designed to screen liquid based, thin layer slides 
circumvent many of the technical problems faced in conventional pap smear. In 
1999, Takahashi et al found that an interactive computer analysis system, the 
autocyte screen yielded a false negative rate of only 1.8%.11 
          In 1999, Bishop et al reported that autocyte screen detected an improved 
sensitivity in the detection of SIL, with the computer assisted screening yielding a 
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98% sensitivity rate compared to a sensitivity rate of 89% by manual screening 
alone12. 
          When used in conjunction with thin layer slides, computer assisted 
screening devices offer tremendous promise for the future, particularly at a time 
when the number of cytotechnologists is decreasing and demand for screening 
increasing. 
To date no study has subjected these technologies to the rigor of the current 
gold standard colposcopy. 
                        
             In 1998, Papillo et al, found a statistically significant increase in 
specificity of diagnosis of SIL of the thin prep 81% over the conventional Pap 
smear 72%.13 
              In 1999, Diaz Rosario et al, found equivalent specificity as determined 
by biopsy proven dysplasia between thin prep 74% and conventional pap 79%14.           
 
Molecular testing of residual material in vial: 
                        An unexpected benefit of liquid based thin layer cytology was 
discovered upon the realization that abundant cellular material remained in the 
vial after production of the slide. With the advancement of molecular testing, 
however biologists begin using the residual material to test for the presence of 
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infectious organism. To date, successful out of vial testing has been shown for 
HPV, Chlamydia gonorrhea and HSV. 
            
           Recently results of 2 large clinical trials showed that detection of high 
oncogenic risk HPV types using hybrid capture ll assay effectively separates 
patients with a cytological diagnosis of ASCUS group into a group of high 
likelihood of having high grade CIN 2 or CIN 3 and a group that has no increased 
risk of having high grade CIN15.                           
This triage strategy has been shown to reduce unnecessary colposcopic 
examination in 45% to 60% of women with ASCUS reduce the morbidity, 
anxiety and cost associated with that procedure. As these procedures require lab 
facility and trained man power these things are not followed in low resource 
settings.16                
Screening with combined modalities: 
     In 2002, Vassilokos et al, found that combination of high risk HPV 
detection and automated screening of liquid based thin layer pap smears could 
separate women with cervical lesions that were ASCUS or higher grade lesions 
into a human review group from a group with negative cytological findings for an 
automated review only. The authors predict that 51% of patients would be 
classified as negative and avoiding the costly review while maintaining 99.6% 
negative predictive value. Similar combination modality is actively being pursued 
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in an effort to achieve more sensitive yet cost – effective cervical cancer 
screening programmes and probably represents the future of cervical screening17.   
Down staging: 
Screening for cervical cancer by visual inspection was widely advocated by 
WHO in 1980s as a way to provide screening services in low resource settings in 
which cytology was not available.18  
 
          Large study with 44,970 women was conducted which detected HSIL and 
cancer with 62% sensitivity and 89% specificity for invasive cancers.19 
 
          Bharva et al and Sujatha  et al used down staging as screening method  in 
3600 women and detected HSIL with sensitivity of 93% and specificity of 37%  
 
Because of the poor performance of down staging in these studies most 




                   When cervicography was first introduced several small studies were 
conducted that suggested that it was superior to cervical cytology for detection of 
CIN II, III and cervical cancer. More recently, two large well designed screening 
studies critically evaluated the performance of cervicography and compared it 
with HPV DNA testing and cervical cytology as a screening test. The sensitivity 
of cervicography when performed under routine conditions was found to be poor. 
Cervicography correctly identified only 52% of all the biopsy confirmed HSIL 
and invasive cervical cancers. The specificity of cervicography was reasonable, 
however. Only 5% of women were referred for colposcopy on the basis of an 
abnormal cervigram .20  
 Direct visual inspection methods: 
          These include inspection of cervix after applying acetic acid and lugol’s 
iodine. Many studies confirm that DVI is more sensitive but less specific.DVI 
identified 88% of biopsy confirmed SIL, whereas cytology and cervicography 
identified only 63%.so the Italian study by cecchini et al concluded that DVI 
more sensitive but less specific.  
In 1999, six large well controlled studies of DVI have been published from 
India, Zimbabwe, china and South Africa.     
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Study by sankaranarayanan et al in 1999, showed that DVI has sensitivity ratio of 
1.54(p<0.001) but the specificity was lower than cytology. (DVI specificity 68% 
while cytology has 89%)  
          In 1999, chirenge et al in Zimbabwe studied DVI on 2148 patients and 
found that DVI is sensitive in 77% and specific in 64% in detection of HSIL and 
cancer. 
Studies by Denny et al in 2002, in South Africa on 2698 women revealed 
that VIA are 69.8% sensitive and 79.3% specific in detecting HSIL.21 
          Basu et al in 2003, studied VIA on 5881 women in India. The study had 
sentivity of 55.7% and specificity of 82% in detecting CIN II and above lesions. 
          Sankaranarayanan et al in 2003, studied 4444 women with VIA to detect 
CIN II and above lesions. This study showed that VIA is sensitive in detecting 
82.6% and the specificity was 86.5%. All patients were subjected to VIA, VILI & 
PAP SMEAR CYTOLOGY and positive cases were subjected to biopsy. Based 
on the result VIA & VILI were considered to be suitable alternative screening test 
to cytology for detecting cervical neoplasia in low resource settings.22 
           A study was conducted by SANKARANARAYANAN et al in 
collaboration with Calcutta cervical cancer early detection group on visual 
inspection with acetic acid and cytology in early detection of cervical neoplasia. 
Study was conducted in 5881 women between 30 – 64 years of age who were 
screened by VIA/VILI/CYTOLOGY. Positive cases were subjected to biopsy.                         
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            Study conducted at Fatima Jinnah College, Department of obstetrics and 
gynecology, Lahore involving 501 women for comparison of visual inspection of 
cervix and Pap smear for cervical cancer screening. Of these, 156 subjects were 
positive with VIA (28.96%) ,while Pap smear was positive in 78 cases (14.4%). 
The accuracy of VIA was 77.5% compared to 52.8% for Pap smear. They 
concluded that VIA was more sensitive and highly specific.             
            Cervical cancer project at university of Zimbabwe / JHPIEGO  conducted 
a study in 1090 women to compare VIA with cytology .They concluded that VIA 
was highly sensitive and could be valuable in detection of precancerous lesions of 
the cervix but emphasis to increase the specificity of VIA was made.23 
            The study by Division of Cancer Epidemiology and Genetics, National 
cancer Institute, Maryland, USA (Jeronimo J, Morales O) involving 1921 
asymptomatic women compared the efficacy of VIA AND PAP SMEAR as a 
screening modality for detecting cancer cervix. They concluded that VIA is good 
screening method not only in low resource settings but also in well equipped 
health centers.  
           Study conducted by Department of Obstetrics and Gynecology, John 
Hopkins Medical center, Baltimore, MD (Biumenthal PD, Gaffikin L, Chirenje 
ZM, McGrath   J, Womack S.Shah K) using 2199 women to detect cancer cervix 
using visual inspection methods, HPV and Pap smear showed that in countries 
with limited resources but with the capacity for HPV testing, sequential testing 
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involving the use of VIA followed by HPV could yield fewer false positive cases 
than the use of VIA alone.   
Department of Obstetrics and Gynecology, Cleveland Clinic Foundation  
conducted a study with 1997 women of age 35-45 years to estimate the sensitivity 
and specificity of VIA and to use it as a primary screening for intraepithelial 
neoplasia. Visual inspection yielded normal results in 1445 women low grade 
intraepithelial neoplasia in 525 (36%), high grade in 21(1%), cancer cervix in 
6(0.3%). The sensitivity was 65% for smaller lesions and 89% for larger lesions. 
They concluded that VIA can be used as a screening modality in developing 
countries.  
                                 
Cost effectiveness of cervical cancer screening strategies: 
               Goldie et al, in 2001 estimated the clinical benefits and cost 
effectiveness of cytology, VIA and HPV testing in South Africa. According to 
this model, using VIA and treating women with positive results of screening 
during the same visit was effective. This single visit strategy was estimated to be 
cost effective and reduce cervical cancer incidence by 26% with a cost of US $ 14 
per YLS. The least effective strategy was cytologic examination, which would 
reduce cervical cancer incidence by 19%, with a cost of US$ 81 per YLS.                   
          Mandelblatt et al, in 2002, estimated the cost effectiveness of screening 
programmes for women aged 35 to 55 years in Thailand. This model suggest that 
 26
using VIA to screen women every five years reduced cervical cancer incidence by 
31%  at a cost of US$263 per YLS and HPV DNA testing reduces cancer 
incidence by 20% at a cost of 672 to 3477 US $ per YLS. The model suggested 
that cytologic screening would be least cost effective in reducing cancer incidence 
by 11% at a cost of US$ 1459 per YLS.24   
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Cervical cancer incidence/ mortality; Cost-
effectiveness; establishment of a service











Detection rates of CIN2-3Cervical cancer
incidence/mortality; Cost-effectiveness;
establishment of a service and training
platform for cervical cancer prevention. 
Cross-sectional 
study 













Test characteristics; Acceptability, efficacy,
complications of cryotherapy;
establishment of a service and training
platform for cervical cancer prevention. 
Cross-sectional 
study 
VIA, cytology Nigeria 2000 women 
aged 30-64 
years 
Test characteristics; Acceptability, efficacy,
complications of cryotherapy;
establishment of a service and training












Test characteristics; Acceptability, efficacy,
complications of cryotherapy;
establishment of a service and training







Calcutta, India 12,000 
women aged 
30-64 years 
Test characteristics; Acceptability, efficacy,
complications of cryotherapy;
establishment of a service and training







Bombay, India 5000 women 
aged 30-59 
years 
Test characteristics; Acceptability, efficacy,
complications of cryotherapy;
establishment of a service and training















2003 USPSTF  
guidelines 
When to start 
screening 
Age 18 or with 
onset of sexual 
intercourse 
Age 21 or 
about  3 yrs 
after onset of 
vaginal 
intercourse 
Age 21 or 
about  3 yrs 
after onset of 
vaginal 
intercourse 
Age 21 or 
about  3 yrs 


















Annually  until 
age 30 using 
either 
conventional 
or liquid based 
cytology  
Every 3 yrs 
  Age 30 or 






Age 30 or 




no history of 
CIN 2 or 3 
may screen 
every 2-3 yrs 
 
When to stop 
screening 





set upper age 




































Existing methods of screening for cervical lesions7: 
1. Cytological evaluation:      
 *Pap smear 
 *Liquid based cytology 
 *Computerized devices like auto pap, 
 *Autonet, auto screen. 
2. Visual inspection approaches: 
  *Visual inspection with acetic acid and lugol’s iodine. 
  *Cervicography 
  *Speculoscopy 
  *Down staging 
 3. Aided visual inspection 
  *gynoscopy 
  *avioscopy 
3. COLPOSCOPY 
   * Colposcopy 
   *Colpomicroscopy 
   *Videocolpomicroscopy 
   *Computerized digital imaging colposcopy 
4. NOVAL APPROACHES 
   *fluorescence speculoscopy 
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   * AgNor: new molecular marker that stands for silver stained nucleolar region. 
Alternate screening methods: 
         A. carcinogenic HPV testing. 
         b.cellular markers like mRNA expression of E6/E7 transcript, p-16 markers 
of disease progression. 
 
Existing screening outcome26 
Method                  sensitivity               specificity 
a. pap smear 
CIN I                          68.1%                      94.6% 
CIN II                          83.3%                    90.3% 
b. VIM   
CIN I                         60.5%                     80% 
CIN II                         73.3%                      77.6% 
c. cervicography 
CIN I                            52.6%                       93.2% 
CIN II                             72.3%                       90.5% 
 
 31
AIM OF STUDY: 
¾ To identify the incidence of cervical lesions in sexually active 
asymptomatic women using VIM. 
¾ To compare the efficacy of VIM with colposcopy. 
¾ To evaluate the feasibility of VIM as a mass screening for cervical lesions 
in low resource settings. 
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TYPE OF STUDY: 
A prospective observational study on asymptomatic women of reproductive age 
group. 
DURATION OF STUDY: 
                        August 2008 to September 2009  
MATERIAL AND METHODS: 
This is a hospital based prospective study conducted at Institute of social 
obstetrics and Government Kasturba Gandhi Hospital for Women and children, 
Triplicane, Chennai-5 from August 2008 to September 2009. 
          This study comprises study subject of 734 women who were attending 
general and gynecology OPD. All 734 patients were subjected to visual 
inspection and magnification (VIA/VILI) and bimanual pelvic examination. All 
these patients were subjected to colposcopy and biopsy was done in all patients. 
 
INCLUSION CRITERIA 
¾ Sexually active women between 20-40 yrs 
¾ Non-pregnant women 
¾ Both nulliparous and multiparous 
¾ Women attending general and gynecology OPD  for screening on their own 




¾ Women with symptoms like vaginal discharge, pain etc 
¾ Pregnant women 
¾ Severe ill health 
¾ Postpartum until 12 wks 
¾ Overt growth in cervix 
¾ Previous treatment for cancerous lesions  
¾ Allergy to acetic acid and iodine 
¾ Those who had undergone hysterectomy 
¾ Women on hormonal therapy 
¾ Women below 20yrs and above 40yrs of age 
¾ Women those who are not sexually active 
¾ Women with h/o surgery on cervix  
  
IARC CRITERIA FOR INTERPRETATION OF VIA/VILI: 
VIA POSITIVE: 
   Well defined, sharp, distinct, dense acetowhite areas with or without   raised 
margins abutting the squamo columnar junction in transformation zone. 
     Strikingly dense acetowhite areas in columnar epithelium. 
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     Condyloma and  leukoplakia occurring closer to the squamocolumnar 
junction turning intensely white after application of acetic acid. 
VIA NEGATIVE: 
¾ No acetowhite lesion on cervix. 
¾ Polyp protruding through the cervix with bluish white acetowhite areas. 
¾ Nabothian cysts. 
¾ Faint line or ill-defined acetowhitening at squamo columnar junction 
¾ Shiny, pinkish white, cloudy white, bluish white faint patchy or 
indefinite margins, blending with rest of the cervix. 
¾ Angular, irregular dilating, acetowhite lesion resembling geographical 
area far away from the transformation zone (satellite lesion). 
¾ Ill defined patch, pale acetowhite in inflamed unhealthy, ulcerated 
cervix with bleeding and mucopurulent discharge. 
¾ Red spots on cervix against pinkish white background after applying 
acetic acid. 
¾ Streak like acetowhitening in the columnar epithelium. 
¾ Dot like areas in endocervix, which are due to grape like columnar 




Dense, thick, bright mustard yellow or saffron yellow iodine non uptake areas 
abutting the squamocolumnar junction in transformation zone. 
VILI NEGATIVE:  
• Normal cervix when squamous epithelium turns mahogany brown or black 
and columnar epithelium does not change colour, no yellow areas seen. 
• In ectropion, when an extension area of columnar epithelium with regular 
margins on ectocervix remaining without colour change. 
• Patchy, indistinct, illdefined, colourless or partially brown areas are seen in 
the cervix. 
• Non or partial iodine uptake, pale areas comparable to preexisting 
nabothian follicle or polyps are seen. 
• Stripping or leopard skin appearance associated with T.vaginalis infection. 
• When pepper like non iodine uptake areas seen in the squamous epithelium 
far away from squamocolumnar junction. 
• When satellite, thin, yellow, non iodine uptake areas with angular or 




Reporting visual inspection findings:27 
Normal: 
               Smooth pink 
               Clear mucoid secretion 
               External os: central hole round in nulliparous and slit like in multiparous 
               Atrophic in postmenopausal women    
Abnormal findings: 
     Infection                   -redness and congestion in general . 
       a. Chlamydia          - mucopurulent activity 
       b. Gonorrhea          - prominent vascularity,  
                                        ectopy, hypertrophy. 
       C.Trichomoniasis   - strawberry cervix.                                                                                
LSIL: 
              Flat smooth surface, indistinct borders like feathered or geographic 
pattern, faint aceto white change. 
HSIL: 
            Sharply demarcated areas, straight contour, distinct aceto white reaction, 
most prompt, persistent, prominent aceto whitening, coarse vascular pattern, 
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Malignant change: 
       Squamous carcinoma- irregular surface, sharply defined borders, coarse 
punctuations and mosaicism, atypical vessels with hallmark of 
neovascularisation. 
       Adenocarcinoma- stark acetowhiteness of fused, irregular heaps of glandular 
villi seen in transformation zone. 
CRITERIA FOR SCREENING 
¾ Should be accurate and reproducible 
¾ Test should be acceptable to people and reasonably inexpensive 
¾ Adequate follow up of positives should be ensured 
¾ Involves minimal or no expenditure to individuals and health services 
¾ Undesired harm due to screening should be avoided 
 
MATERIALS NEEDED 
¾ Examination table with leg rest 
¾ Good light source and ring lens magnifying system 
¾ Digital video colposcope with magnification 25X 
¾ Sterile bivalve speculum 
¾ Pair of gloves  
¾ Cotton swabs, cotton tipped buds, gauze  
¾ Ring forceps,vulsellam,  cervical punch biopsy forceps 
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¾ Normal saline,3%acetic acid,lugol’s iodine solution,10%formalin, 
     Monsel’s solution 
¾ A steel/plastic container with 0.5%chlorine in which used gloves are 
immersed  
¾ A plastic bucket with polythene bag to dispose contaminated swabs and 
waste items 
METHODOLOGY OF STUDY 
¾ Patient in lithotomy position 
¾ Introduce bivalve self retaining speculum 
¾ Characteristic of discharge noted if present 
¾ Inspection of unstained cervix 
¾ Inspection after application of acetic acid 
¾ Inspection after application  of Lugol’s iodine 
¾ Inspection of fornices and vaginal wall 
¾ Findings recorded and patient was advised to come after  2 to 3 weeks  
¾ Patients undergone VIA/VILI were subjected to colposcopy 
¾ Cervix, vagina and vulva inspected for lesions  
¾ Colposcopic directed biopsy with punch biopsy  done in all patients 




RESULTS AND ANALYSIS 
Table 1: 





Legend Frequency percentage 
 20 1 12 1.6 
21 to  25 2 258 35.1 
26 to 30 3 251 34.2 
31 to 35 4 165 22.5 
36 to 40 5 48 6.5 
Total  734 100 
 
In this study, age group taken was between 21-35 years which 




   













AGE AT MARRIAGE 
(n=734) 
Legend Age at marriage Frequency Percentage 
1 15 to 20 228 31.1 
2 21 to 25 492 67 
3 26 to 30 14 1.9 
 Total 734 100 
 
 











AGE AT MARRIAGE GROUP




















Legend Parity frequency Percentage 
0 Nulliparous 34 4.6% 
1 Para 1 203 27.7% 
2 Para 2 429 58.4% 
3 Para 3 63 8.6% 
4 Para 4 and 
Above 
5 0.7% 
 Total 734 100% 
 
This study comprises women of 67% belonging to second parity 
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Contraception practiced in this study group: 
(n=734) 
Legend Contraception frequency Percentage 
0 No contraception 166 22.6 
1 PS 410 55.9 
2 Barrier 74 10.1 
3 OCP 45 6.1 
4 IUCD 39 5.3 
 Total 734 100 
 
Our study showed that most of our Para 2 women undergo permanent 
method of sterilization. Hence with the loss of fear of pregnancy their 
sexual activity also increases putting them at higher risk for cervical 
lesions 
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Comparison of Biopsy results and age group 
(n=734) 
Legend Age Biopsy normal Biopsy positive 
1 18-20 12(1.6%) 0 
2 21-25 250(34.1%) 8(1.1%) 
3 26-30 204(27.8%) 47(6.4%) 
4 31-35 126(17.2%) 39(53%) 
5 36-40 44(6%) 4(0.5%) 
 total 636(86.6%) 98(13.4%) 
 
Symmetrical measure: 
           The appropriate significance is established (0.000). 
 
This study showed that age distribution in positive lesion was between 
26-35 years (47% in 26- 30 years, 53% in 31-35 years).  
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Comparison of Age at marriage with lesion: 
(n=734) 
Legend Age at marriage Biopsy normal Biopsy positive
1 15-20 144(19.6%) 84(11.4%) 
2 21-25 478(65.1%) 14(1.9%) 
3 26-30 14(1.9%) 0 
 Total 636(86.6%) 98(13.4%) 
Symmetrical measure: 
           The appropriate significance is established(0.000). 
 
In this study, there is higher incidence of positive biopsy when these 
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Comparison of Parity with biopsy results: 
(n=734) 
Parity Normal biopsy Positive biopsy 
Nulli 34(4.6%) 0 
Para 1 201(27.4%) 2(0.3%) 
Para 2 372(50.7%) 57(7.8%) 
Para 3 29(4%) 34(4.6%) 
Para 4 and above 0 5(0.7%) 
Total 636(86.6%) 98(13.4%) 
Symmetrical measure: 
           The appropriate significance is established(0.000). 
 
In this study among positive lesions ie, 13.4%, 13.1% belong to Para 2 
and above and no nulliparous women was positive.  
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Education compared with positive lesions in colposcopy guided 
biopsy: 
(n=734) 
Legend Education Biopsy normal Biopsy positive
0 Nil 23(3.6%) 15(15.3%) 
1 1-5 standard 155(24.4%) 52(53.1%) 
2 6-12 standard 355(55.8%) 31(31.6%) 
3 Degree 103(16.2%) 0 
Symmetrical measure: 
           The appropriate significance is established(0.000). 
 
 
In this study positive lesions are significantly associated with low level 
of literacy. Those who undergone graduation has nil lesions indicating 
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Comparing Socioeconomic status with lesion: 
(n=734) 
Legend  Income /month Biopsy normal Biopsy positive
1 < Rs.2000 10(1.4%) 56(7.6%) 
2 Rs.2000-5000 323(44%) 36(4.9%) 
3 >Rs.5000 303(41.3%) 6(0.8%) 
TOTAL  636(86.6%) 98(13.4%) 
Symmetrical measure: 
           The appropriate significance is established(0.000). 
 
 
In this study out of 13.4% positive lesions 7.6% belong to very low 
income group of < Rs.2000/month and 4.9%  belong to income of Rs. 
2000- 5000.  Only 0.8% of income more than Rs.5000 /month showed 
positivity. 





Influence of Contraception method adopted on cervical lesion : 
(n=734) 




No contraception 166 (22.6) 143(19.5%) 23(3.1%) 
PS 410(55.9) 344(46.9%) 66(9%) 
Barrier 74(10.1) 74(10.1%) 0 
Ocp 45(6.1) 42(5.7%) 3(0.4%) 
Iucd 39(5.3) 33(4.5%) 6(0.8%) 
Total 734(100) 636(86.6%) 98(13.4%) 
Symmetrical measure: 
           The appropriate significance is not established(0.124). 
 
In our study positive lesions are more in women practicing 
permanent sterilization as they were out of fear of pregnancy and prone 
to have increased sexual activity making them a high risk group. 
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Table 11: 











0 NO LESION 644 87.7 
1 POSITIVE 90 12.3 




COLPOSCOPY result in this study: 
(n=734) 
Legend COLPOSCOPY FREQUENCY PERCENTAGE
0 NO LESION 637 86.8 
1 POSITIVE 97 13.2 
 TOTAL 734 100 
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Comparision of VIA/VILI result with BIOPSY report: 
(n=734) 
VIA/VILI Biopsy normal Biopsy positive 
Normal 636(86.6%) 8(1.1%) 
Positive 0 90(12.3%) 
Total 636(86.6%) 98(13.4%) 
Symmetrical measure: 
           The exact significance is  established(0.000). 
 
Table 14: 
Comparison of Colposcopy with biopsy: 
(n=734) 
colposcopy Biopsy normal Biopsy positive 
Normal 636(86.6%) 1(0.1%) 
Positive 0 97(13.2%) 
Total 636(86.6%) 98(13.4%) 
  
Symmetrical measure: 
           The exact significance is  established(0.000). 
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Comparison of VIA/VILI WITH COLPOSCOPY: 
(n=734) 
VIA/VILI Colpo normal Colpo positive 
Normal 636 8 
Positive 1 89 
Total 637 97 
Symmetrical measure: 
           The exact significance is  established(0.000). 
 
Both in VIA/VILI and Colposcopy, it was noted that all the positive 
women were found to be positive when biopsy confirmation was 
sought. However, there were minor differences with both the methods 
missing on negative women. Hence though the methods were near 
complete in their positive predictive value, they were lacking when 
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COMPARISION OF BIOPSY TYPES: 
(n=734) 
Biopsy positive Frequency Percentage 




LSIL 57 7.8% 
HSIL 9 1.2% 
Total 734 100% 
 
Most of the positive biopsies were LSIL lesions and the women were 



























SENSITIVITY 91.84% 98.98% 91.75% 
SPECIFICITY 100% 100% 99.84% 
PPV 100% 100% 98.89% 
NPV 98.76% 99.84% 98.76% 



















This prospective observational study analyses the efficacy of visual inspection 
methods (VIA/VILI) with colposcopy and cervical biopsy and to choose VIA and 
VILI as an easily interpretable low cost but effective method for detecting 
cervical lesions. 
     In our study, age group taken was between 21-35 years which constitute about 
91.8% of patients studied. Similarly, study conducted in AIIMS, New Delhi in 
2003 to evaluate and compare test performance of visual inspection of cervix by a 
doctor and paramedical worker, included study group of patients with 64% 
belonging to 30-39 years28. 
                   In a study conducted in Mumbai, regarding concurrent evaluation of 
visual, cytological HPV testing as screening methods for detection of cervical 
neoplasia had study group of age between 30-39 in majority and showed that 
younger women had higher rate of positive result in visual tests. 
                 In our study, age at marriage was less than 20 in 31.1% which is 
similar to study conducted in obs & gyn department in institute of medical 
sciences in 2007 with 500 patients. Among them 30.4% of the study group had 
their marriage at age less than 20 years. 
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            Similarly, study conducted in AIIMS, New Delhi in March 2003 for 
detecting cervical lesions on women with mean age at first sexual intercourse was 
19+/- 3.3 years.   
                In our study most of women were Para 1 and Para 2 which is consistent 
with practice of our women for small family norm. 
               Our study showed that most of our Para 2 women undergo permanent 
method of sterilization. Hence with the loss of fear of pregnancy their sexual 
activity also increases, putting them at higher risk for cervical lesions 
                In this study, positive lesions are significantly associated with low level 
of literacy. Those who undergone graduations have nil lesions indicating that 
literacy have positive influence in reducing cervical lesions. 
              Similarly, study on Health literacy, cervical cancer risk factor and 
distress in low income Africo- American women seeking colposcopy concluded 
that low level of health literacy is associated with increased level of distress 
among women at high risk for developing cervical cancer29. 
                         In this study ,out of 13.4% positive lesions 7.6% belong to very 
low income group of < Rs.2000/month and 4.9%  belong to income of Rs. 2000- 
5000.  Only 0.8% of the study group with income more than Rs.5000 /month 
showed positivity. 
               Similarly, study conducted in Institute of medical sciences, Lahore in 
2007 showed that all women with CIN belonged to low socio economic status and 
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about 24-80% belonged to very low socio economic status of income between Rs. 
3000- 5000/month. 
                   This study showed that age distribution in positive lesion was 
between 26-35 years (47% in 26- 30 years, 53% in 31-35 years). A study 
conducted at Institute of medical sciences, Lahore  in 2007  showed that majority 
of women with CIN (60%) were between 35-45 years which also showed that   
there is higher incidence of positive biopsy when this women marry at  early age 
and expose themselves to longer period of sexual activity. 
                  In this study, among positive lesions ie, 13.4%, 13.1% belong to Para 
2 and above and no nulliparous women was positive.  
      In a study conducted by IARC,a multicentric case control study 
on role of parity and HPV in cervical cancer, found that there was direct 
association between number of full term pregnancy and squamous cell carcinoma 
risk30. The odds ratio for seven full term pregnancy or more was 3.8(95% CI 2.7-
5.5) compared with nulliparous women and 2.3(CI1.6-3.2) compared with women 
who had one or two full term pregnancy. 
                      In our study, positive lesions are more in women practicing 
permanent sterilization as they were out of fear of pregnancy and prone to have 
increased sexual activity making them a high risk group. Couple practicing 
barrier methods (condom) are at nil risk in this study. 
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                        In a paper published on cancer of cervix and its prevention : still a 
public health concern which highlighted the risk factors showed that recent 
research is showing that long term user of OCP are at high risk of cervical cancer 
and regular user of barrier methods of contraception have low risk for cervical 
lesions.   
                      In our study, both in VIA/VILI and Colposcopy, it was noted that 
all the positive women were found to be positive when biopsy confirmation was 
sought. However, there were minor differences with both the methods missing on 
negative women. Hence though the methods were near complete in their positive 
predictive value, they were lacking when negative predictive value was 
considered. 
                     In this study, most of the positive biopsies were LSIL lesions and the 
women were treated accordingly. 1.2% of HSIL women were counselled for 
further definitive management. 
                     Results of our study was comparable with study conducted in 
Institute of medical sciences ,Lahore showed  LSIL in 4.1%  and HSIL in 1.8% 






Variables in the Equation
33.029 4 .000
-5.175 10205.923 .000 1 1.000 .006
9.738 2.105 21.403 1 .000 16949.295
8.211 1.498 30.062 1 .000 3682.657
5.640 1.056 28.500 1 .000 281.417
8.011 2 .018
16.204 9804.510 .000 1 .999 1.1E+07
14.848 9804.510 .000 1 .999 2807355
3.985 4 .408
-36.924 17174.738 .000 1 .998 .000
-20.997 16022.507 .000 1 .999 .000
-20.198 16022.507 .000 1 .999 .000
-19.404 16022.507 .000 1 .999 .000
.774 .132 34.255 1 .000 2.168



















B S.E. Wald df Sig. Exp(B)
Variable(s) entered on step 1: VAR00004, VAR00007, VAR00008, VAR00016.a. 
 
BINARY LOGISTIC REGRESSION MODEL  WAS USED TO IDENTIFY 
THE ASSOCIATION OF RISK FACTORS WITH RESPECT TO  BIOPSY 
ABNORMALITY. 
THE  VARIABLES  AGE(4),AGE AT  MARRIAGE(GROUP)(7), 
DURATION OF SEXUAL EXPOSURE (16)  ARE SIGNIFICANTLY 








                                              SUMMARY 
                 Of 734 cases, 90 cases were found to be VIA/VILI positive and 644 
cases were VIA/VILI negative. 
              Of 734 cases studied, colposcopy was positive in 97 (13.2%). Among 97 
cases who were colposcopy positive, VIA/ VILI was positive in 90 cases. 
             Colposcopy guided Biopsy was done in all 734 cases. Of that, biopsy was 
positive in 98 cases. Among 98 cases who were biopsy positive, 97 cases were 
positive for colposcopy.  
              The sensitivity of VIA/VILI in detecting preinvasive lesions  was 
91.84% and specificity was 100% when compared with colposcopy which has 
sensitivity 98.98% and specificity 100%. 
              The positive predictive value of VIA/VILI was 100% and its negative 
predictive value was 98.76%. Similarly the positive and negative predictive value 
in detecting cervical lesions with colposcopy in asymptomatic women was found 
to be 100% and 99.84% respectively. 








• There is an enormous increase in the incidence of cancer cervix and in 
India, it is increasing in geometric proportion.  
• This can be controlled only with the introduction of mass screening 
programme in a coordinated way.  
• Till recently, all our screening programmes were Pap smear based and with 
the inherent difficulties in performing and interpreting Pap smear results in 
our set up, it was not surprising that these programmes could not give the 
expected results.  
• Hence, the emphasis was shifted to visual inspection methods with acetic 
acid and Lugol’s iodine.  
• This method could sustain due to its simplicity and ease of performing in 
mass programmes.  
• The other advantage with this method is that the results are available 
immediately thereby precluding with the need for the women to visit the 
health centers on more than one occasion.  
• This is a very important consideration in rural areas.  
• Moreover the specificity and sensitivity of these visual inspection based 
tests were also equally good  91.84%  and  98.98 %  respectively. 
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• Hence for resource restricted settings, VIA /VILI is a real boon for mass 
screening. 
• This study further emphasizes the need for programmed screening of all 
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ANNEXURE – I  PROFORMA 
 
COMPARING  THE EFFICACY OF  VISUAL INSPECTION 
WITH ACETIC ACID AND LUGOL’S  IODINE AS A 
SCREENING TOOL FOR DETECTING CERVICAL LESIONS 
IN ASYMPTOMATIC WOMEN OF REPRODUCTIVE  AGE 
GROUP WITH COLPOSCOPY AS GOLD STANDARD. 
 
                  INSTITUTE OF SOCIAL OBSTETRICS 
                                           CHENNAI 5. 
                               
1.Serial Number …………                                          [  ] [  ] [  ] 
                           
2.Date of recruitment ……………………………  [  ][  ]-[  ][  ]-[  ][  ][  ][  ]   




………………………………………………………         
 
5.Age………………   [  ][  ]                             S.E.S:[  ] 
    . 
6.Education………………………………………………………   [  ]  
 (1-Nil; 2-Primary; 3-Middle; 4-High school; 5-College; 9-Not known) 
 
7.Age at menarche(99-Not known)………………………………… [ ][ ] 
 
 8.When did you have your last menstruation?...................................[  ]. 
(1-less than 12 months ago ; 2-more than 12 months ago) 
 
9.Marital status……………………………………………………    [  ] 
(1-Married;2-Widow;3-Separated;8-Other;9-Not known) 
 
10.Age at marriage or first sexual intercourse(99-Not known)……  [  ][  ] 
 
11.Total number of pregnancies……………………………….        [   ][  ] 
 
12. Total number of  Abortions……………………………………  [   ][  ] 
. 
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13.Findings of VIA…………………………………………………[   ] 
(1-Negative;2-Positive;3-Positive,Invasive) 
 
14. .Findings of VILI………………………………………………[   ] 
(1-Negative; 2-Positive;3-Positive,Invasive) 
 
15.Colposcopy…………………………………………………      [   ] 
(1-Not done;2-Satisfactory,entireSCJ seen;3-Unsatisfactory,SCJpartially seen;  4-
Unsatisfactory,SCJ not seen;5-Invasive cancer) 
 
16.Colposcopic diagnosis(Date________  )…………………………[   ] 
(1-Not done;2-Normal;3-Squamous metaplasia;4-Leukoplakia; 
5-Condyloma/wart 6-Propbable low grade lesion:Atypia/CIN-1; 
7- Propbable high grade lesion CIN-2,3;8-invasive cancer;9-other  
   explain-------------------------------------------------------) 
 
               A                                   B                               C 
17.Colposcopy findings 
(A-to mark the findings of initial examination;B&C-for review 
 examinations after treatment;AW-acetowhite area;M-mosaic;P-punctation; 
AV-atypical vessels;G-growth;I-iodine negative area) 
 
18.Biopsy taken?(1-Yes;2-No)………………………........................[   ] 
 
19.Histopathology of biopsy……………………………………[   ][   ] 
(00-not done;01-inflamation/chronic cervicitis;02-squamous metaplasia; 
03-HPV infection;04-atypia;05-CIN-I;06-CIN-II;07-CIN-III;08-early 
 invasive carcinoma 09-invasive squamous cell carcinoma; 
10-invasive adeno carcinoma;99-other 
(Explain __________________________________) 
 
20.IF invasive cancer, stage………………………………(   ) 
 
MASTER CHART- ANNEXURE II
COLPO NO. NAME AGE AGE GROUP S.E.S EDUCA
AGE AT 
MARRIAGE-
GROUP PARITY CONTRA VAI/ VILI COLPOS BIOPSY
6 anitha 20 1 2 1 1 0 0 0 0 0
2 asha 20 1 2 2 1 0 0 0 0 0
341 farida 20 1 2 2 1 1 0 0 0 0
351 farida 20 1 2 2 1 0 0 0 0 0
3 fathima 20 1 2 2 1 0 0 0 0 0
353 kondamma 20 1 2 1 1 1 0 0 0 0
5 priya 20 1 3 3 1 0 0 0 0 0
4 seetha 20 1 3 3 1 0 0 0 0 0
352 sriradha 20 1 3 3 1 1 0 0 0 0
1 usha 20 1 3 3 1 0 0 0 0 0
9 fousiya 21 2 2 1 1 1 3 0 0 0
8 harini 21 2 2 1 1 1 2 0 0 0
442 jeeva 21 2 2 2 1 0 0 0 0 0
441 jenifier 21 2 2 1 1 0 0 0 0 0
7 lakshmi 21 2 2 2 1 1 2 0 0 0
10 sampathku 21 2 3 3 1 1 0 0 0 0
443 leela 22 2 2 2 1 2 0 0 0 0
11 logeswari 22 2 2 2 1 1 3 0 0 0
13 sinduja 22 2 3 3 1 0 0 0 0 0
12 thiruseivi 22 2 3 3 1 1 0 0 0 0
18 ammu 23 2 2 2 1 1 2 0 0 0
355 asha 23 2 2 2 1 0 0 0 0 0
126 ayesa 23 2 2 1 2 1 3 0 0 0
132 anitha 23 2 2 1 2 1 3 0 0 0
19 aseena 23 2 2 3 1 0 0 0 0 0
116 afdab 23 1 2 2 2 1 2 0 0 0
465 bakiyam 23 2 2 2 2 2 1 0 0 0
15 barathy 23 2 2 2 1 2 1 0 0 0
404 begam 23 2 2 2 1 1 2 0 0 0
124 bharathi 23 2 2 3 2 1 3 0 0 0
17 darani 23 2 2 2 1 1 4 0 0 0
448 deepavathy 23 2 2 1 2 1 0 0 0 0
117 divya 23 1 2 2 2 1 0 0 0 0
453 esabella 23 2 2 1 2 1 2 0 0 0
135 fathima 23 2 2 2 2 1 0 0 0 0
399 gandghi 23 2 2 2 1 1 0 0 0 0
454 gandghi 23 2 2 3 2 1 0 0 0 0
23 geetha 23 2 2 3 1 2 1 0 0 0
461 geetha 23 2 2 2 2 1 2 0 0 0
16 gomathy 23 2 2 1 1 2 0 0 0 0
143 harini 23 2 2 3 2 1 0 0 0 0
401 hemavathi 23 2 2 2 1 1 4 0 0 0
456 indra 23 2 2 2 1 2 1 0 0 0
130 jammuna 23 2 2 2 2 1 3 0 0 0
118 janma 23 2 2 2 2 1 2 0 0 0
354 kaliselvi 23 2 2 1 1 1 4 0 0 0
464 kamatchi 23 2 2 1 2 1 4 0 0 0
449 kasiammal 23 2 2 1 2 1 0 0 0 0
400 kavita 23 2 2 2 1 1 2 0 0 0
120 kiruba 23 2 2 2 2 1 4 0 0 0
137 kokila 23 2 2 2 2 1 0 0 0 0
129 komala 23 2 2 2 2 1 3 0 0 0
139 laila 23 2 2 1 2 1 2 0 0 0
405 magalam 23 2 2 2 1 1 2 0 0 0
458 mani 23 2 2 2 2 1 3 0 0 0
136 mathi 23 2 2 2 2 1 2 0 0 0
123 meenakshi 23 2 2 2 2 1 2 0 0 0
127 mohana 23 2 1 3 2 0 0 0 0 0
445 nalini 23 2 3 2 2 1 0 0 0 0
144 nandhini 23 2 3 3 2 0 0 0 0 0
467 nandhini 23 2 3 3 2 1 2 0 0 0
406 nila 23 2 3 3 1 1 3 0 0 0
356 nisha 23 2 3 3 1 2 1 0 0 0
121 padma 23 2 3 3 2 1 2 0 0 0
451 parvathy 23 2 3 3 1 1 2 0 0 0
450 preethi 23 2 3 3 2 1 2 0 0 0
446 priya 23 2 3 3 2 1 0 0 0 0
125 pushpa 23 2 3 3 2 1 4 0 0 0
131 pushpa 23 2 3 3 2 1 2 0 0 0
466 radha 23 2 3 3 2 1 2 0 0 0
140 radika 23 2 3 3 2 1 2 0 0 0
128 ragavi 23 2 3 3 2 1 3 0 0 0
138 ragavi 23 2 3 3 2 1 3 0 0 0
141 rahini 23 2 3 3 2 1 2 0 0 0
460 rajamani 23 2 3 3 2 1 0 0 0 0
373 reka 23 2 3 3 1 1 0 0 0 0
403 roopa 23 2 3 3 1 1 3 0 0 0
578 sarala 23 2 3 3 2 1 3 0 0 0
457 saryna 23 2 3 3 2 1 2 0 0 0
463 sellammal 23 2 3 3 2 1 3 0 0 0
134 selvi 23 2 3 3 2 1 0 0 0 0
402 suganthi 23 2 3 3 2 0 0 0 0 0
14 tamilselvi 23 2 3 3 1 2 1 0 0 0
619 thaillamma 23 2 3 3 2 1 4 0 0 0
122 thangam 23 2 3 3 2 1 2 0 0 0
459 thangam 23 2 3 3 2 1 2 0 0 0
452 theras 23 2 3 3 1 1 2 0 0 0
444 usgha 23 2 3 3 2 1 0 0 0 0
342 varalakshm 23 2 3 3 1 2 0 0 0 0
119 vasuki 23 2 3 3 2 1 4 0 0 0
133 vasuki 23 2 3 3 2 1 4 0 0 0
142 vennila 23 2 3 3 2 1 3 0 0 0
21 vidhya 23 2 3 3 1 0 0 0 0 0
447 vimal 23 2 3 3 2 1 2 0 0 0
20 vimala 23 2 3 3 1 0 0 0 0 0
455 myena 23 2 2 2 1 1 4 1 1 1
22 nirmaladev 23 2 2 2 1 1 3 1 1 1
331 ajima 24 2 2 0 1 2 1 0 0 0
497 allagma 24 2 2 1 2 1 2 0 0 0
42 akila 24 2 2 2 1 1 2 0 0 0
503 amsa 24 2 2 2 2 2 0 0 0 0
478 anandhi 24 2 2 1 2 1 2 0 0 0
45 anjalai 24 2 2 2 1 1 0 0 0 0
43 anjali 24 2 2 3 1 0 0 0 0 0
374 afida 24 2 2 1 1 1 2 0 0 0
160 archana 24 2 2 2 2 1 3 0 0 0
44 aruna 24 2 2 2 1 1 0 0 0 0
585 aruna 24 2 2 0 2 1 2 0 0 0
622 asha 24 2 2 3 2 0 0 0 0 0
30 barathy 24 2 2 2 1 2 1 0 0 0
495 bhavani 24 2 2 2 2 1 0 0 0 0
483 bhuvana 24 2 2 3 2 1 2 0 0 0
147 celin 24 2 2 2 2 1 3 0 0 0
415 chandra 24 2 2 2 1 2 0 0 0 0
471 chitra 24 2 2 2 2 0 0 0 0 0
38 darani 24 2 2 2 1 1 4 0 0 0
468 deepa 24 2 2 2 2 1 3 0 0 0
157 devika 24 2 2 2 2 2 1 0 0 0
166 durga 24 2 2 1 2 1 0 0 0 0
165 enitha 24 2 2 2 2 1 2 0 0 0
40 geetha 24 2 2 2 1 2 1 0 0 0
41 gomathi 24 2 2 2 1 2 1 0 0 0
328 govindamm 24 2 2 1 1 1 0 0 0 0
164 indira 24 2 2 2 2 1 2 0 0 0
502 indrira 24 2 2 1 2 3 1 0 0 0
490 indumathi 24 2 2 2 2 1 4 0 0 0
145 jammuna 24 2 2 2 2 1 3 0 0 0
330 jamuna 24 2 2 1 1 2 1 0 0 0
498 jamuna 24 2 2 3 2 1 0 0 0 0
379 janaki 24 2 2 1 1 2 1 0 0 0
146 janma 24 2 2 2 2 1 2 0 0 0
496 jaya 24 2 2 1 2 1 3 0 0 0
491 kanaga 24 2 2 1 2 1 3 0 0 0
28 kanchana 24 2 2 2 1 0 0 0 0 0
39 kanchana 24 2 2 2 1 1 0 0 0 0
586 kanchana 24 2 2 1 2 1 0 0 0 0
377 kandamma 24 2 2 2 1 2 1 0 0 0
500 kanimozhi 24 2 2 2 2 2 1 0 0 0
479 kanmni 24 2 2 1 2 0 0 0 0 0
357 kannagi 24 2 2 2 1 1 2 0 0 0
363 kannama 24 2 2 2 1 1 0 0 0 0
361 karpagam 24 2 2 2 1 1 4 0 0 0
418 kayalvizhi 24 2 2 2 1 2 1 0 0 0
481 keerthana 24 2 2 1 2 1 3 0 0 0
362 keertika 24 2 2 2 1 2 0 0 0 0
150 kiruba 24 2 2 2 2 1 4 0 0 0
156 kokila 24 2 2 2 2 2 1 0 0 0
27 komala 24 2 2 2 1 0 0 0 0 0
162 komala 24 2 2 2 2 1 3 0 0 0
420 kuppu 24 2 2 2 1 1 2 0 0 0
161 laila 24 2 2 1 2 1 2 0 0 0
29 lakshmi 24 2 2 2 1 1 2 0 0 0
159 lalitha 24 2 2 2 2 1 3 0 0 0
480 latha 24 2 2 2 2 2 4 0 0 0
501 leelavathy 24 2 2 2 2 2 1 0 0 0
148 linda 24 2 2 2 2 1 3 0 0 0
151 lisa 24 2 2 3 2 1 3 0 0 0
152 lisa 24 2 2 3 2 1 3 0 0 0
33 logeswari 24 2 2 2 1 1 3 0 0 0
476 magesh 24 2 2 2 2 2 1 0 0 0
358 mahalaksh 24 2 2 1 1 2 1 0 0 0
167 malini 24 2 2 2 2 0 0 0 0 0
416 malliga 24 2 2 2 1 1 2 0 0 0
411 manjula 24 2 2 2 1 2 1 0 0 0
149 maya 24 2 2 2 2 0 0 0 0 0
378 megali 24 2 1 2 1 2 1 0 0 0
375 muniamma 24 2 1 1 1 2 1 0 0 0
489 muniamma 24 2 1 2 2 1 2 0 0 0
582 muniamma 24 2 3 1 2 1 0 0 0 0
419 murugama 24 2 3 0 2 1 4 0 0 0
475 murugamm 24 2 3 2 2 1 2 0 0 0
153 nadhithiya 24 2 3 1 2 0 0 0 0 0
584 nalini 24 2 3 3 2 2 1 0 0 0
380 nathiya 24 2 3 3 19 1 2 0 0 0
499 nathiya 24 2 3 3 2 2 1 0 0 0
407 neela 24 2 3 3 1 2 0 0 0 0
383 nirmala 24 2 3 3 1 1 0 0 0 0
170 nisa 24 2 3 3 2 2 1 0 0 0
155 padma 24 2 3 3 2 1 2 0 0 0
169 palaniyamm 24 2 3 3 2 1 0 0 0 0
381 paramu 24 2 3 3 1 2 0 0 0 0
412 parasakthi 24 2 3 3 1 2 1 0 0 0
384 ponni 24 2 3 3 1 2 1 0 0 0
168 poornima 24 2 3 3 2 1 0 0 0 0
486 poornima 24 2 3 3 2 0 0 0 0 0
504 priya 24 2 3 3 2 1 3 0 0 0
26 rada 24 2 3 3 1 2 0 0 0 0
163 radika 24 2 3 3 2 1 2 0 0 0
482 rajam 24 2 3 3 2 1 2 0 0 0
410 rama 24 2 3 3 2 1 2 0 0 0
581 rangamma 24 2 3 3 2 2 1 0 0 0
382 rani 24 2 3 3 1 1 4 0 0 0
472 rani 24 2 3 3 2 0 0 0 0 0
173 rashitha 24 2 3 3 2 2 1 0 0 0
359 revathy 24 2 3 3 1 2 1 0 0 0
408 roja 24 2 3 3 1 2 0 0 0 0
470 roopini 24 2 3 3 2 1 3 0 0 0
413 selvam 24 2 3 3 1 2 1 0 0 0
623 sengodi 24 2 3 3 2 1 4 0 0 0
492 shankari 24 2 3 3 2 1 4 0 0 0
583 shoba 24 2 3 3 2 1 3 0 0 0
485 sindghu 24 2 3 3 2 2 1 0 0 0
487 srimalar 24 2 3 3 2 2 1 0 0 0
488 suba 24 2 3 3 2 1 0 0 0 0
493 suba 24 2 3 3 2 2 1 0 0 0
621 sudha 24 2 3 3 2 1 2 0 0 0
34 suja 24 2 3 3 1 2 1 0 0 0
171 sujatha 24 2 3 3 2 1 2 0 0 0
35 sunitha 24 2 3 3 1 2 1 0 0 0
32 tarini 24 2 3 3 1 2 1 0 0 0
158 thangam 24 2 3 3 2 2 1 0 0 0
477 thangam 24 2 3 3 2 2 1 0 0 0
484 thangaman 24 2 3 3 2 1 4 0 0 0
31 thilagavath 24 2 3 3 1 2 1 0 0 0
36 udaya 24 2 3 3 1 1 2 0 0 0
37 uma 24 2 3 3 1 1 2 0 0 0
376 uma 24 2 3 3 1 1 0 0 0 0
579 uma 24 2 3 3 2 1 2 0 0 0
360 vadivu 24 2 3 3 1 1 0 0 0 0
474 valliammal 24 2 3 3 2 0 0 0 0 0
174 vani 24 2 3 3 2 1 0 0 0 0
620 vani 24 2 3 3 2 0 0 0 0 0
24 varalakshm 24 2 3 3 1 0 0 0 0 0
154 varsa 24 2 3 3 2 0 0 0 0 0
172 vasantha 24 2 3 3 2 1 0 0 0 0
46 vasanthi 24 2 3 3 1 1 2 0 0 0
469 veena 24 2 3 3 2 1 0 0 0 0
624 vijaya 24 2 3 3 2 2 1 0 0 0
494 vinotha 24 2 3 3 2 1 4 0 0 0
409 yasmin 24 2 3 3 1 2 1 0 0 0
625 yasmin 24 2 3 3 2 1 3 0 0 0
580 zebin 24 2 2 2 2 1 0 0 0 0
414 myena 24 2 2 2 1 2 1 1 1 1
417 vadivu 24 2 2 2 1 2 1 1 1 1
473 seetha 24 2 2 1 2 2 1 0 1 2
25 rahimunish 24 2 2 0 1 3 0 1 1 3
512 anusa 25 2 2 2 2 2 1 0 0 0
626 devi 25 2 2 3 2 1 0 0 0 0
178 devika 25 2 2 2 2 2 1 0 0 0
50 gomathy 25 2 2 1 1 2 0 0 0 0
47 govindamm 25 2 2 1 1 1 0 0 0 0
52 harshini 25 2 2 1 1 1 2 0 0 0
507 hema 25 2 2 2 2 1 3 0 0 0
51 kanchana 25 2 2 2 1 1 0 0 0 0
589 kayalvizhi 25 2 2 3 2 1 2 0 0 0
508 kiran 25 2 2 2 2 2 1 0 0 0
49 lalitha 25 2 2 3 1 1 2 0 0 0
48 latha 25 2 2 3 1 1 2 0 0 0
627 magalam 25 2 2 3 2 2 1 0 0 0
177 mathi 25 2 2 2 2 2 1 0 0 0
175 maya 25 2 2 2 2 0 0 0 0 0
179 meenakshi 25 2 2 2 2 1 2 0 0 0
176 mohana 25 2 1 3 2 0 0 0 0 0
511 munnira 25 2 3 0 2 1 3 0 0 0
398 rahamathn 25 2 3 3 2 2 0 0 0 0
421 rajalakshm 25 2 3 3 1 1 0 0 0 0
590 sangavi 25 2 3 3 2 1 0 0 0 0
510 selvarani 25 2 3 3 2 2 1 0 0 0
513 sivagami 25 2 3 3 2 1 4 0 0 0
422 sumathy 25 2 3 3 1 1 0 0 0 0
588 susheela 25 2 3 3 2 1 2 0 0 0
587 suzanne 25 2 3 3 2 1 2 0 0 0
397 tamilselvi 25 2 3 3 1 2 1 0 0 0
514 thangaman 25 2 3 3 2 2 1 0 0 0
506 valar 25 2 3 3 2 2 1 0 0 0
505 valli 25 2 3 3 2 1 2 0 0 0
509 vennila 25 2 3 3 2 1 0 0 0 0
462 viji 25 2 3 3 2 2 1 0 0 0
515 banu 26 3 2 2 2 2 0 0 0 0
519 dhanalaksh 26 3 2 2 2 2 1 0 0 0
591 durga 26 3 2 2 2 1 3 0 0 0
628 eswari 26 3 2 1 2 1 0 0 0 0
629 fuiia 26 3 2 1 2 2 1 0 0 0
180 geetha 26 3 2 3 2 2 1 0 0 0
182 jeyanthi 26 3 2 2 2 2 1 0 0 0
181 kalai 26 3 2 1 2 1 0 0 0 0
631 kumudha 26 3 2 2 2 1 2 0 0 0
183 lavanya 26 3 2 3 2 1 3 0 0 0
517 maya 26 3 2 1 2 2 1 0 0 0
423 nalli 26 3 3 3 1 2 0 0 0 0
593 prabha 26 3 3 3 2 1 0 0 0 0
713 puppitha 26 3 3 3 2 1 2 0 0 0
520 sarathy 26 3 3 3 2 1 3 0 0 0
516 savithiri 26 3 3 3 2 2 1 0 0 0
630 sheeba 26 3 3 3 2 2 1 0 0 0
518 sultbana 26 3 3 3 2 1 3 0 0 0
592 sumathy 26 3 3 3 2 2 1 0 0 0
53 vijaya 26 3 3 3 1 2 1 0 0 0
54 seethalaks 26 3 2 1 1 4 1 1 1 2
714 analakshm 27 3 2 2 2 2 0 0 0 0
186 banu 27 3 2 2 2 2 0 0 0 0
56 chandra 27 3 2 1 1 2 1 0 0 0
187 eniya 27 3 2 2 2 2 1 0 0 0
58 gayathri 27 3 2 2 1 3 1 0 0 0
596 gayathri 27 3 2 3 2 2 1 0 0 0
598 gowri 27 3 2 2 2 2 1 0 0 0
184 jeyanthi 27 3 2 2 2 2 1 0 0 0
634 kalavathy 27 3 2 2 2 2 1 0 0 0
595 kanga 27 3 2 2 2 2 1 0 0 0
637 mangalam 27 3 2 2 2 2 1 0 0 0
190 manju 27 3 2 1 2 2 1 0 0 0
594 meena 27 3 2 2 2 2 1 0 0 0
524 nalini 27 3 3 3 2 2 1 0 0 0
635 nallu 27 3 3 3 2 1 0 0 0 0
188 nandhini 27 3 3 3 2 2 0 0 0 0
599 narmddha 27 3 3 3 2 2 2 0 0 0
525 preetha 27 3 3 3 2 2 1 0 0 0
526 prizilla 27 3 3 3 2 2 1 0 0 0
636 pushpa 27 3 3 3 2 2 1 0 0 0
523 radhika 27 3 3 3 2 2 1 0 0 0
189 roja 27 3 3 3 2 2 0 0 0 0
521 sangeetha 27 3 3 3 2 3 0 0 0 0
185 sarala 27 3 3 3 2 1 4 0 0 0
633 selvi 27 3 3 3 2 2 1 0 0 0
597 shankari 27 3 3 3 2 2 1 0 0 0
522 sumi 27 3 3 3 2 2 1 0 0 0
632 vasanthi 27 3 3 3 2 1 2 0 0 0
385 rajeswari 27 3 2 1 1 2 0 1 0 1
386 varalakshm 27 3 2 1 1 2 1 1 1 1
57 latha 27 3 2 1 1 3 1 1 1 2
387 premavathi 27 3 2 1 1 3 1 1 1 2
55 valarmathy 27 3 2 2 1 2 0 1 1 2
650 akila 28 3 2 3 2 1 4 0 0 0
644 angammal 28 3 2 3 2 2 1 0 0 0
538 ananthi 28 3 2 2 2 2 1 0 0 0
209 anupriya 28 3 2 1 2 2 1 0 0 0
715 anulaxmi 28 3 2 3 2 1 3 0 0 0
213 ashwini 28 3 2 1 2 2 1 0 0 0
191 ayesha 28 3 2 3 2 1 0 0 0 0
192 ahsa 28 3 2 3 2 1 0 0 0 0
200 banu 28 3 2 2 2 2 0 0 0 0
533 banu 28 3 2 0 2 2 1 0 0 0
216 bavana 28 3 2 3 2 2 1 0 0 0
600 buelah 28 3 2 2 2 2 1 0 0 0
61 chandra 28 3 2 1 1 2 1 0 0 0
364 chitrkala 28 3 2 2 1 2 1 0 0 0
539 eswari 28 3 2 2 2 2 0 0 0 0
540 gandhi 28 3 2 1 2 2 4 0 0 0
196 geetha 28 3 2 3 2 2 1 0 0 0
315 girija 28 3 2 3 3 1 2 0 0 0
640 hamsa 28 3 2 2 2 2 1 0 0 0
207 harini 28 3 2 3 2 2 1 0 0 0
528 indhu 28 3 2 2 2 2 1 0 0 0
529 indu 28 3 2 1 2 2 1 0 0 0
534 jankai 28 3 2 1 2 2 1 0 0 0
602 jansi 28 3 2 2 2 2 1 0 0 0
601 jennila 28 3 2 2 2 2 1 0 0 0
193 jeyanthi 28 3 2 2 2 2 1 0 0 0
210 jothiyamma 28 3 2 1 2 2 1 0 0 0
541 kalaivani 28 3 2 0 2 2 1 0 0 0
217 kavitha 28 3 2 2 2 2 1 0 0 0
195 komala 28 3 2 1 2 1 2 0 0 0
639 kribavaty 28 3 2 2 2 2 1 0 0 0
214 kumari 28 3 2 3 2 2 1 0 0 0
527 kuppu 28 3 2 3 2 2 1 0 0 0
651 lalitha 28 3 2 1 2 2 1 0 0 0
646 madamma 28 3 2 2 2 2 4 0 0 0
194 mahalaksh 28 3 2 3 2 1 3 0 0 0
537 marimuthu 28 3 2 3 2 2 1 0 0 0
642 meera 28 3 2 1 2 2 0 0 0 0
197 megala 28 3 2 2 2 2 1 0 0 0
317 mituna 28 3 1 2 3 1 0 0 0 0
641 moghana 28 3 1 2 2 2 4 0 0 0
425 muthu 28 3 3 1 1 2 4 0 0 0
532 myena 28 3 3 2 2 2 1 0 0 0
649 mythili 28 3 3 1 2 2 1 0 0 0
208 nandhini 28 3 3 3 2 2 0 0 0 0
215 neeraja 28 3 3 3 2 2 1 0 0 0
716 nirmala 28 3 3 3 2 1 4 0 0 0
424 ponni 28 3 3 3 1 2 1 0 0 0
536 radhika 28 3 3 3 2 2 1 0 0 0
643 rajammal 28 3 3 3 2 2 1 0 0 0
198 revathy 28 3 3 3 2 2 1 0 0 0
199 revathy 28 3 3 3 2 2 1 0 0 0
603 ruba 28 3 3 3 2 2 1 0 0 0
647 sampath 28 3 3 3 2 1 4 0 0 0
388 saradha 28 3 3 3 1 2 1 0 0 0
212 saroja 28 3 3 3 2 2 1 0 0 0
201 shantha 28 3 3 3 2 2 1 0 0 0
316 sita 28 3 3 3 3 2 1 0 0 0
211 sofia 28 3 3 3 2 1 2 0 0 0
206 suda 28 3 3 3 2 2 1 0 0 0
605 suganya 28 3 3 3 2 2 1 0 0 0
604 sumithra 28 3 3 3 2 2 0 0 0 0
63 tamilselvi 28 3 3 3 1 3 1 0 0 0
648 usha 28 3 3 3 2 2 1 0 0 0
638 valli 28 3 3 3 2 2 1 0 0 0
203 vani 28 3 3 3 2 2 1 0 0 0
204 vani 28 3 3 3 2 2 1 0 0 0
645 vani 28 3 3 3 2 1 2 0 0 0
64 vanitha 28 3 3 3 1 2 1 0 0 0
202 vanitha 28 3 3 3 2 2 1 0 0 0
535 veni 28 3 3 3 2 2 1 0 0 0
65 vennila 28 3 3 3 1 2 1 0 0 0
59 vijaya 28 3 3 3 1 2 1 0 0 0
205 wahida 28 3 3 3 2 1 3 0 0 0
728 yasmin 28 3 3 3 2 1 2 0 0 0
72 eswari 28 3 2 2 1 2 1 1 1 1
426 girija 28 3 2 1 2 2 1 1 1 1
68 jeenath 28 3 2 0 1 2 0 1 1 1
530 roghini 28 3 2 2 2 2 0 1 1 1
531 sangeetha 28 3 2 2 2 2 1 0 1 1
71 tulasi 28 3 2 2 1 2 1 1 1 1
343 amsaveni 28 3 2 1 1 2 1 1 1 2
62 dhanalaksh 28 3 2 1 1 2 1 1 1 2
69 nirmala 28 3 2 1 1 2 1 1 1 2
60 rajeswari 28 3 2 1 1 4 1 1 1 2
365 revathi 28 3 2 1 1 2 1 1 1 2
66 sadana 28 3 2 0 1 2 1 1 1 2
73 seethalaks 28 3 2 1 1 4 1 1 1 2
67 sujitha 28 3 2 0 1 2 1 1 1 2
70 santhi 28 3 2 0 1 3 1 1 1 3
336 suganthi 28 3 2 1 1 3 1 1 1 3
545 ambika 29 3 2 2 2 2 2 0 0 0
657 anbumalar 29 3 2 2 2 2 1 0 0 0
230 akila 29 3 2 1 2 2 1 0 0 0
658 bhavani 29 3 2 2 2 2 1 0 0 0
76 chandra 29 3 2 1 1 2 1 0 0 0
718 chellam 29 3 2 1 2 3 1 0 0 0
430 devi 29 3 2 1 1 3 1 0 0 0
547 devi 29 3 2 2 2 2 1 0 0 0
544 durga 29 3 2 2 2 2 1 0 0 0
226 eniya 29 3 2 2 2 2 1 0 0 0
318 girija 29 3 2 3 3 1 2 0 0 0
652 jasmin 29 3 2 2 2 2 1 0 0 0
229 jeyanthi 29 3 2 2 2 2 1 0 0 0
223 kalai 29 3 2 1 2 1 0 0 0 0
653 kalliammal 29 3 2 3 2 2 1 0 0 0
219 komala 29 3 2 1 2 1 2 0 0 0
231 komala 29 3 2 3 2 2 1 0 0 0
389 latha 29 3 2 1 1 2 1 0 0 0
607 mala 29 3 2 2 2 2 1 0 0 0
654 mala 29 3 2 2 2 2 1 0 0 0
78 malarvizhi 29 3 2 1 1 2 1 0 0 0
220 malarvizhi 29 3 2 2 2 2 1 0 0 0
366 mano 29 3 2 1 1 2 1 0 0 0
221 megala 29 3 1 2 2 2 1 0 0 0
719 myena 29 3 3 3 2 2 1 0 0 0
655 mytheli 29 3 3 3 2 2 1 0 0 0
542 nirubha 29 3 3 3 2 2 1 0 0 0
606 nithya 29 3 3 3 2 2 1 0 0 0
232 raga 29 3 3 3 2 2 1 0 0 0
543 sakthi 29 3 3 3 2 2 1 0 0 0
222 sarala 29 3 3 3 2 1 4 0 0 0
717 saroja 29 3 3 3 2 2 1 0 0 0
656 savitha 29 3 3 3 2 2 1 0 0 0
234 savithri 29 3 3 3 2 2 1 0 0 0
218 seethalaks 29 3 3 3 2 2 1 0 0 0
224 shantha 29 3 3 3 2 2 1 0 0 0
319 sita 29 3 3 3 3 2 1 0 0 0
228 sulochana 29 3 3 3 2 2 1 0 0 0
546 tamilarasi 29 3 3 3 2 2 1 0 0 0
77 vani 29 3 3 3 1 2 1 0 0 0
233 vijayalaxmi 29 3 3 3 2 2 1 0 0 0
225 vimala 29 3 3 3 2 2 1 0 0 0
227 wahida 29 3 3 3 2 1 3 0 0 0
429 krthika 29 3 2 2 1 2 1 1 1 1
80 mariamma 29 3 2 1 1 3 1 1 1 1
427 vennila 29 3 2 1 1 2 0 1 1 1
367 gandghi 29 3 2 1 1 3 1 1 1 2
344 jyothi 29 3 2 0 1 2 1 1 1 2
74 rajeswari 29 3 2 1 1 4 1 1 1 2
428 sowmiya 29 3 2 2 1 2 1 1 1 2
75 valarmathy 29 3 2 2 1 2 0 1 1 2
79 santhi 29 3 2 0 1 3 1 1 1 3
81 amala 30 3 2 2 1 2 0 0 0 0
663 amsa 30 3 2 2 2 2 1 0 0 0
666 amsaveni 30 3 2 2 2 1 4 0 0 0
553 annalakshm 30 3 2 0 2 2 1 0 0 0
390 bavani 30 3 2 2 1 2 2 0 0 0
244 chithra 30 3 2 1 2 1 0 0 0 0
608 easwari 30 3 2 2 2 2 1 0 0 0
89 gayathri 30 3 2 2 1 2 1 0 0 0
551 jayakodi 30 3 2 1 2 2 1 0 0 0
245 jayalaxmi 30 3 2 3 2 1 0 0 0 0
664 jothi 30 3 2 1 2 2 1 0 0 0
554 kalivani 30 3 2 2 2 2 0 0 0 0
665 kannama 30 3 2 2 2 1 4 0 0 0
432 kaveri 30 3 2 0 1 2 1 0 0 0
556 kuruvama 30 3 2 1 2 2 1 0 0 0
236 mahalaksh 30 3 2 3 2 2 0 0 0 0
86 malarvizhi 30 3 2 1 1 2 1 0 0 0
237 malarvizhi 30 3 2 2 2 2 1 0 0 0
552 malini 30 3 2 2 2 3 1 0 0 0
557 mytheli 30 3 3 1 2 2 1 0 0 0
667 parveen 30 3 3 3 2 2 1 0 0 0
550 radahabai 30 3 3 3 2 2 1 0 0 0
243 reka 30 3 3 3 2 2 1 0 0 0
246 rosalin 30 3 3 3 2 2 1 0 0 0
661 rosamma 30 3 3 3 2 2 1 0 0 0
82 sakthidevi 30 3 3 3 1 2 0 0 0 0
247 sankari 30 3 3 3 2 2 1 0 0 0
555 sarala 30 3 3 3 2 2 4 0 0 0
659 savithiri 30 3 3 3 2 2 1 0 0 0
548 seetha 30 3 3 3 2 2 1 0 0 0
235 seethalaks 30 3 3 3 2 2 1 0 0 0
660 shantha 30 3 3 3 2 2 1 0 0 0
242 sulochana 30 3 3 3 2 2 1 0 0 0
662 susi 30 3 3 3 2 2 1 0 0 0
84 tamilselvi 30 3 3 3 1 3 1 0 0 0
431 usha 30 3 3 3 2 2 1 0 0 0
240 vanitha 30 3 3 3 2 2 1 0 0 0
241 vimala 30 3 3 3 2 2 1 0 0 0
549 durga 30 3 2 2 2 2 1 1 1 1
87 jeenath 30 3 2 0 1 2 0 1 1 1
91 devi 30 3 2 1 1 3 0 1 1 2
83 dhanalaksh 30 3 2 1 1 2 1 1 1 2
238 gowri 30 3 2 1 2 2 4 1 1 2
368 indu. 30 3 2 1 1 2 1 1 1 2
85 latha 30 3 2 1 1 3 1 1 1 2
337 laxmi 30 3 2 1 1 2 3 1 1 2
345 mangi 30 3 2 1 1 3 0 1 1 2
90 nallama 30 3 2 1 1 3 0 1 1 2
88 nirmala 30 3 2 1 1 2 1 1 1 2
335 prema 30 3 2 1 1 2 1 1 1 2
239 ridha 30 3 2 1 2 2 4 1 1 2
92 tharani 30 3 2 0 1 3 1 1 1 2
671 bharathi 31 4 2 2 2 2 0 0 0 0
732 deepa 31 4 2 2 3 2 1 0 0 0
609 ganga 31 4 2 2 2 2 1 0 0 0
729 girija 31 4 2 1 2 2 1 0 0 0
252 jamuna 31 4 2 2 2 2 1 0 0 0
669 kanmani 31 4 2 1 2 2 1 0 0 0
248 karpagam 31 4 2 0 2 2 1 0 0 0
558 leevathi 31 4 2 2 2 2 1 0 0 0
670 malar 31 4 2 2 2 3 1 0 0 0
610 menaka 31 4 1 2 2 2 1 0 0 0
721 monia 31 4 1 2 2 2 1 0 0 0
720 sindu 31 4 3 3 2 2 1 0 0 0
249 usha rani 31 4 3 3 2 2 1 0 0 0
251 yalini 31 4 3 3 2 3 1 0 0 0
668 yamuna 31 4 3 3 2 2 1 0 0 0
250 yasoda 31 4 3 3 2 1 0 0 0 0
93 andal 31 4 2 2 1 2 1 1 1 2
391 layana 31 4 2 2 1 2 1 1 1 2
369 ramya 31 4 2 2 1 2 0 1 1 2
94 rohini 31 4 2 1 1 2 1 1 1 2
434 anjali 32 4 2 1 2 1 0 0 0 0
559 deena 32 4 2 2 2 2 1 0 0 0
254 eswari 32 4 2 2 2 2 1 0 0 0
255 gitanjali 32 4 2 2 2 2 1 0 0 0
320 gowri 32 4 2 3 3 2 1 0 0 0
261 janaki 32 4 2 2 2 3 1 0 0 0
253 karpagam 32 4 2 0 2 2 1 0 0 0
613 kuruvamm 32 4 2 1 2 2 0 0 0 0
673 lakshmi 32 4 2 1 2 2 1 0 0 0
256 lavanya 32 4 2 2 2 2 1 0 0 0
672 madhu 32 4 2 5 2 2 1 0 0 0
677 murugamm 32 4 3 0 2 2 1 0 0 0
722 niranjana 32 4 3 3 2 2 1 0 0 0
733 padmini 32 4 3 3 3 2 1 0 0 0
730 raji 32 4 3 3 2 2 1 0 0 0
260 ranjitha 32 4 3 3 2 2 0 0 0 0
676 ruba 32 4 3 3 2 2 1 0 0 0
433 saroja 32 4 3 3 1 3 1 0 0 0
674 suganya 32 4 3 3 2 2 1 0 0 0
612 suguna 32 4 3 3 2 2 1 0 0 0
257 usha 32 4 3 3 2 2 1 0 0 0
560 vasantha 32 4 3 3 2 2 1 0 0 0
259 viji 32 4 3 3 2 2 1 0 0 0
258 yalini 32 4 3 3 2 3 1 0 0 0
675 parvathy 32 4 2 1 2 2 1 1 1 1
435 rathi 32 4 2 1 2 2 0 1 1 1
346 santhi 32 4 2 0 1 3 0 1 1 1
611 sulthana 32 4 2 2 2 2 1 1 1 1
321 eswari 32 4 2 2 1 2 4 1 1 2
334 laxmi 32 3 2 1 1 2 3 1 1 2
338 naseem 32 4 2 2 1 3 0 1 1 2
333 thara 32 3 2 1 1 3 1 1 1 2
332 rahimunish 32 2 2 0 1 4 0 1 1 3
681 anjala 33 4 2 1 2 2 1 0 0 0
267 asha 33 4 2 2 2 2 1 0 0 0
271 bagyam 33 4 2 2 2 2 1 0 0 0
678 deva 33 4 2 2 2 2 1 0 0 0
262 kala 33 4 2 3 2 2 1 0 0 0
723 kanaga 33 4 2 1 2 2 1 0 0 0
679 lalitha 33 4 2 2 2 2 1 0 0 0
562 lavanya 33 4 2 3 2 2 1 0 0 0
263 meera 33 4 2 0 2 3 1 0 0 0
614 nagammal 33 4 3 1 2 2 1 0 0 0
268 nila 33 4 3 3 2 2 1 0 0 0
682 padmini 33 4 3 3 2 2 1 0 0 0
564 pappathi 33 4 3 3 2 2 1 0 0 0
270 rihana 33 4 3 3 2 3 1 0 0 0
563 ruby 33 4 3 3 2 2 1 0 0 0
96 sabana 33 4 3 3 1 2 1 0 0 0
266 sadana 33 4 3 3 2 1 0 0 0 0
680 santhanam 33 4 3 3 2 3 1 0 0 0
561 saraswathi 33 4 3 3 2 2 1 0 0 0
615 sivagami 33 4 3 3 2 2 1 0 0 0
683 subha 33 4 3 3 2 2 1 0 0 0
269 viji 33 4 3 3 2 2 1 0 0 0
264 yasoda 33 4 3 3 2 1 0 0 0 0
392 suji 33 4 2 1 2 2 0 1 1 1
95 kokila 33 4 2 2 1 3 1 0 1 2
97 rihana 33 4 2 1 1 3 0 1 1 2
265 snega 33 4 2 1 2 3 1 0 1 2
437 sundari 33 4 2 2 1 2 1 1 1 2
436 vijaya 33 4 2 1 1 2 1 1 1 2
98 chithra 33 4 2 1 1 3 1 1 1 3
569 alamalu 34 4 2 2 2 3 1 0 0 0
278 asha 34 4 2 2 2 2 1 0 0 0
438 barani 34 4 2 2 1 2 1 0 0 0
283 daranipriya 34 4 2 2 2 2 1 0 0 0
394 devi 34 4 2 2 1 2 0 0 0 0
693 dhanam 34 4 2 3 2 2 1 0 0 0
685 geetha 34 4 2 2 2 2 1 0 0 0
275 gitanjali 34 4 2 2 2 2 1 0 0 0
282 jeeva 34 4 2 2 2 2 1 0 0 0
274 kala 34 4 2 3 2 2 1 0 0 0
686 kala 34 4 2 2 2 2 1 0 0 0
571 kalpana 34 4 2 1 2 2 1 0 0 0
572 kamsala 34 4 2 2 2 3 1 0 0 0
617 kasthuri 34 4 2 2 2 2 0 0 0 0
694 kirshnaven 34 4 2 3 2 2 1 0 0 0
616 kokila 34 4 2 1 2 3 1 0 0 0
276 lavanya 34 4 2 2 2 2 1 0 0 0
570 maduri 34 4 2 2 2 2 0 0 0 0
695 mangalam 34 4 2 2 2 2 1 0 0 0
272 manjula 34 4 2 3 2 2 1 0 0 0
565 neelavani 34 4 3 3 2 2 1 0 0 0
323 nirosa 34 4 3 3 3 2 1 0 0 0
566 palanimma 34 4 3 3 2 2 1 0 0 0
689 prema 34 4 3 3 2 2 1 0 0 0
281 priya 34 4 3 3 2 2 1 0 0 0
684 radha 34 4 3 3 2 2 1 0 0 0
692 rajammal 34 4 3 3 2 2 1 0 0 0
696 ramayee 34 4 3 3 2 2 0 0 0 0
273 reka 34 4 3 3 2 2 1 0 0 0
687 rohini 34 4 3 3 2 2 1 0 0 0
277 sadana 34 4 3 3 2 1 0 0 0 0
697 saradhi 34 4 3 3 2 2 1 0 0 0
568 sasi 34 4 3 3 2 3 1 0 0 0
567 seeta 34 4 3 3 2 2 1 0 0 0
279 tamilarasi 34 4 3 3 2 2 1 0 0 0
440 thangam 34 4 3 3 1 2 1 0 0 0
691 umyal 34 4 3 3 2 3 1 0 0 0
690 vanaja 34 4 3 3 2 2 0 0 0 0
280 yogalaxmi 34 4 3 3 2 3 1 0 0 0
439 abinaya 34 4 2 1 1 3 1 0 1 1
105 banu 34 4 2 1 1 3 0 1 1 1
104 brinda 34 4 2 1 1 3 0 1 1 1
103 celin 34 4 2 1 1 2 1 1 1 1
370 eswari 34 4 2 2 1 2 1 1 1 1
688 lilly 34 4 2 1 2 2 4 0 1 1
102 nalini 34 4 2 1 1 2 1 1 1 1
101 nithya 34 4 2 1 1 2 1 1 1 1
100 vani 34 4 2 1 1 2 1 1 1 1
106 gandimathi 34 4 2 1 1 3 0 1 1 2
347 kamala 34 4 2 0 1 3 1 1 1 2
99 kokila 34 4 2 2 1 3 1 0 1 2
348 mumtaj 34 4 2 1 1 2 0 1 1 2
393 neela 34 4 2 2 1 3 1 1 1 2
339 ranjani 34 4 2 1 1 2 1 1 1 2
322 wahida 34 4 2 2 1 2 4 1 1 2
573 abirami 35 4 2 2 2 2 1 0 0 0
290 anu 35 4 2 1 2 3 1 0 0 0
698 angammal 35 4 2 3 2 3 0 0 0 0
285 eswari 35 4 2 2 2 2 1 0 0 0
324 gowri 35 4 2 3 3 2 1 0 0 0
577 gunavathi 35 4 2 0 2 2 1 0 0 0
292 jeyanthi 35 4 2 2 2 2 1 0 0 0
724 kalai 35 4 2 2 2 3 0 0 0 0
701 kalyani 35 4 2 1 2 2 1 0 0 0
576 kumari 35 4 2 2 2 2 1 0 0 0
725 madumitha 35 4 2 1 2 2 1 0 0 0
734 malar 35 4 2 3 3 2 1 0 0 0
700 meenachi 35 4 2 2 2 2 1 0 0 0
286 meera 35 4 2 0 2 3 1 0 0 0
289 nila 35 4 3 3 2 2 1 0 0 0
703 nithya 35 4 3 3 2 2 1 0 0 0
291 rada 35 4 3 3 2 2 1 0 0 0
107 sabana 35 4 3 3 1 2 1 0 0 0
702 suseela 35 4 3 3 2 2 1 0 0 0
574 thamari 35 4 3 3 2 2 1 0 0 0
699 thilaga 35 4 3 3 2 2 1 0 0 0
288 usha 35 4 3 3 2 2 1 0 0 0
284 usha rani 35 4 3 3 2 2 1 0 0 0
575 vani 35 4 3 3 2 2 0 0 0 0
109 mary 35 4 2 2 1 2 1 1 1 1
108 andal 35 4 2 2 1 3 1 1 1 2
371 ganga 35 4 2 0 1 3 1 1 1 2
395 jhansi 35 4 2 2 1 3 1 1 1 2
287 snega 35 4 2 1 2 2 1 0 1 2
349 vanitha 35 4 2 0 1 3 0 1 1 2
329 nisha 35 2 2 2 1 3 1 1 1 3
110 krishnaven 36 5 2 1 1 2 1 0 0 0
618 radhika 36 5 3 3 2 2 1 0 0 0
350 sita 36 5 2 1 1 3 1 1 1 2
704 asma 37 5 2 2 2 2 1 0 0 0
326 farhana ba 37 5 2 3 3 2 1 0 0 0
293 latha 37 5 2 2 2 2 1 0 0 0
325 poulin 37 5 3 3 3 2 1 0 0 0
726 rathna 37 5 3 3 2 3 1 0 0 0
731 ropan 37 5 3 3 2 2 1 0 0 0
372 jeeva 37 5 2 2 1 2 1 1 1 3
297 devi 38 5 2 2 2 2 0 0 0 0
705 karbagam 38 5 2 2 2 2 1 0 0 0
706 kiruba 38 5 2 2 2 2 1 0 0 0
707 malar 38 5 2 2 2 2 1 0 0 0
299 meena 38 5 2 2 2 2 1 0 0 0
296 parvathy 38 5 3 3 2 2 0 0 0 0
327 poulin 38 5 3 3 3 2 1 0 0 0
111 renuga 38 5 3 3 1 2 1 0 0 0
112 sindu 38 5 3 3 1 2 1 0 0 0
300 sindu 38 5 3 3 2 2 1 0 0 0
301 swapna 38 5 3 3 2 2 1 0 0 0
295 uma 38 5 3 3 2 2 1 0 0 0
298 usha 38 5 3 3 2 2 0 0 0 0
302 vinoda 38 5 3 3 2 2 0 0 0 0
294 yasmin 38 5 3 3 2 3 1 0 0 0
396 megala 38 5 2 2 1 3 1 1 1 2
727 dhanam 39 5 2 1 2 2 0 0 0 0
306 hema 39 5 2 2 2 2 1 0 0 0
113 janagi 39 5 2 1 1 2 1 0 0 0
114 janani 39 5 2 1 1 2 1 0 0 0
710 kalayni 39 5 2 2 2 2 1 0 0 0
307 malini 39 5 2 2 2 2 1 0 0 0
709 nagammal 39 5 3 1 2 3 1 0 0 0
305 parvathy 39 5 3 3 2 2 0 0 0 0
304 shenbagam 39 5 3 3 2 2 1 0 0 0
308 sindu 39 5 3 3 2 2 1 0 0 0
309 swapna 39 5 3 3 2 2 1 0 0 0
708 valar 39 5 3 3 2 2 1 0 0 0
310 vinoda 39 5 3 3 2 2 0 0 0 0
303 yasmin 39 5 3 3 2 2 0 0 0 0
340 sujatha 39 5 2 0 1 2 1 1 1 3
712 baby 40 5 2 2 2 2 0 0 0 0
711 deepa 40 5 2 2 2 2 1 0 0 0
115 krishnaven 40 5 2 1 1 2 1 0 0 0
313 latha 40 5 2 2 2 2 1 0 0 0
314 meena 40 5 2 2 2 2 1 0 0 0
311 shenbagam 40 5 3 3 2 2 1 0 0 0
312 uma 40 5 3 3 2 2 1 0 0 0
AGE GROUP : SOCIOECCONOMIC STATUS CONTRACEPTION
1- 20 YRS 1- <RS.2000 0- NO CONTRACEPTION
2- 21 -25 YRS 2- RS.2000- RS. 5000 1- PUERPERAL STERILISATION
3- 26-30 YRS 3- >RS5000 2- BARRIER METHOD- CONDOM
4- 31-35 YRS 3- CONTRACEPTIVE PILL
5- 36- 40 YRS 4- INTRAUTERINE CONTRACEPTIVE DEVICE
S
AGR AT MARRIAGE EDUCATION BIOPSY RESULT
1- 15 - 20 YRS 0- NIL 0- NORMAL
2- 21 - 25 YRS 1- 1-5 STANDARD 1- CHRONIC NON SPECIFIC CERVICITIS
3- 26 - 30 YRS 2- 6-12 STANDARD 2- LSIL
3- DEGREE 3- HSIL
PARITY
0- NULLIPAROUS VIA/VILI RESULTS COLPOSCOPY
1- PARA 1 0- NORMAL STUDY 0- NORMAL
2- PARA 2 1- POSITIVE 1- S
3- PARA 3
4- PARA 4 AND ABOVE
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